price_1S0zbDRwqbPyRUJoULRRzYcv

Hereditary Cancer Test

Hereditary Cancer Test

$
49.00
$
49.00

This cancer screening panel looks for genetic changes that increase the risk for many types of cancer. The panel analyzes 63 genes, including BRCA1 and BRCA2, that are related to hereditary cancer.

Bundle & Save on Complete Screening
Most customers add this for a more thorough risk profile — and a discount on the upfront cost.
green check
Reproductive Carrier Screening
Save $29.00 when you buy both tests
Insurance
Self pay
Save $29.00
Questions about billing or insurance?
* Many customers have zero additional cost for their genetic testing, but insurance coverage varies and you may have out-of-pocket costs depending on your coverage. Myriad Genetics will email your cost estimate. If it is greater than $249 per test, please call us 678-729-9104 within 3 days to discuss payment options. Once test results are ready, you may no longer change your payment method.
Most commercial and federally-funded insurance plans cover testing for patients who meet guidelines based on their personal or family history of cancer, and the vast majority of patients incur no out-of-pocket costs for MyRisk® testing.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Why Screening Is Important

  • About 1 in 8 women will be diagnosed with breast cancer in their lifetime, making it one of the most common cancers. Men can also carry BRCA gene mutations.1
  • Risk of breast, ovarian, and other cancers is significantly increased in people with BRCA gene mutations.2,3
  • Knowing your risks can empower you and your doctor to create a personalized healthcare plan to optimize prevention, early detection, and treatment.
  • If you have a family history of cancer, this test is especially important.

What's Included In Your Test

jscreen’s program fee ($10.00) includes access to our genetic counselors and care navigators throughout the testing process
Physician review and test ordering ($39.00)
Virtual care navigation session
1 At-home saliva collection kit
Screening panel that tests over 63 hereditary cancer genes

Who should consider taking this test?

purple arrow pointing down

Anyone interested in learning more about their personal health risk can get tested. The panel is designed for individuals of all ancestries and includes hereditary cancer risks found in people of all different backgrounds.

Testing is especially important for individuals with a personal and/or family history of cancer and those with Ashkenazi Jewish ancestry.

While the test is available to anyone age 18 or older, we often recommend waiting until approximately age 25 depending on family history and other factors.

How long will it take to get results?

purple arrow pointing down

Your kit should arrive 7-10 business days after you complete all registration forms. Test results are provided in an easy to understand report typically available within 3-4 weeks of the sample arriving at the lab. You will have an opportunity to discuss your results with a genetic counselor.

Will genetic testing be covered by my insurance?

purple arrow pointing down

Insurance coverage largely depends on whether your personal and family history of cancer meets established medical guidelines (clinical criteria). For those who meet criteria, 95% of private insurance companies cover testing and 90% of tested customers pay $0 out-of-pocket through coverage and financial assistance (Myriad Genetics data).

If you do not have insurance coverage or you have a high unmet deductible, you can choose to forgo insurance and opt for the self-pay price of $249 for your test. If you cannot afford testing, there are financial assistance programs available for those who qualify.

Clear cost estimates from Myriad Genetics

purple arrow pointing down

1. Self-pay: $298.00 due now. Nothing is billed to insurance.

2. Insurance: $49.00 due now, the rest is billed to your insurance. After Myriad Genetics receives your sample, they will provide you with a cost estimate.

Your estimate will consider:
- Your personal and/or family history of cancer
- Your insurance plan
- Your remaining deductible
- Any copays or coinsurance per your plan
- Eligibility for financial assistance

You will receive an email/text from Myriad Genetics notifying you that your estimate is ready to view. If your estimate shows you’ll have an out-of-pocket cost that creates a hardship, you have options which will be provided to you.

Two women smiling and embracing indoors, one with short gray hair wearing yellow and the other with long dark hair wearing white.Two women smiling and embracing indoors, one with short gray hair wearing yellow and the other with long dark hair wearing white.

What to Expect

Actionable

purple arrow pointing down

Test results are provided in an easy-to-understand report available within 3 weeks of the sample arriving at the lab. If an individual or couple learns that they or their future children are at risk for a genetic disease, a genetic counselor will provide options for family planning or medical care.

Affordable

purple arrow pointing down

jscreen is committed to helping you access reliable and affordable genetic testing. Carrier testing is covered by most insurance plans and Myriad Genetics offers the option of affordable cash pay prices and financial assistance programs for those who qualify.

Peace of mind

purple arrow pointing down

If an action plan is needed, a care navigator will work with you on a plan that fits your needs. You can feel confident knowing that the carrier screen offered through the jscreen program, is the only validated carrier screening panel in the US backed by 20+ peer-reviewed publications and >1.6M patients screened.

Understanding Hereditary Cancer Test

References

1. Levy R. What’s the connection between BRCA and Ashkenazi Jewish ancestry? Dana-Farber Cancer Institute. June 26, 2023. Accessed February 17, 2026. https://blog.dana-farber.org/insight/2023/06/whats-the-connection-between-brca-and-ashkenazi-jewish-ancestry/

2. BRCA gene changes: cancer risk and genetic testing. National Cancer Institute. Updated November 25, 2024. Accessed February 17, 2026. https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet

3. Yoshida R. Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer. 2021;28(6):1167-1180. doi:10.1007/s12282-020-01148-2